6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed May 26, 2026 · 1mo ago · Accession 0001395064-26-000154
Plain English
Takeda Pharmaceutical Company Limited is revising its consolidated financial statements due to a subsequent event. The specific nature and impact of this revision are detailed in Exhibit 99.1.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- May 26, 2026
- Report date
- May 26, 2026
- Document
- form6k_052626x5.htm
- Size
- 234 KB